DAY 4 – November 14, 2009

SESSION VII: Cancer Stem Cells: The Ultimate Target? – Beverly S. Mitchell, MD, Moderator

8:00–8:20

Stem Cell Biology and Cancer

TBD

8:20–8:40

Breast Cancer Stem cells

Max S. Wicha, MD

8:40–9:00

Leukemia Stem Cells

Craig T. Jordan, PhD

9:00–9:20

Myeloma Stem Cells

William H. Matsui, MD

9:20–9:40

Cancer Stem Cells

Benjamin G. Neel, MD, PhD

9:40–10:10

Discussion

10:10–10:30

Break

Session VIII: Targeted Therapy for Cancer: Present and Future – Moderator: TBD

10:30–10:50

Targeting Kinase Pathways: Is One Target Enough?

Neal Rosen, MD, PhD

10:50–11:10

Dasatinib and the Future of CML Therapy

Neil P. Shah, MD, PhD

11:10–11:30

Optimizing Combinations of FLT3 Inhibitors and Chemotherapy

Mark Levis, MD, PhD

11:30–11:50

Genomic Approaches to Targeted Therapy

TBD

11:50–12:10

Targeted Therapy of Solid Tumors

TBD

12:10–12:40

Discussion

Adjourn

Day 1 AgendaDay 2 AgendaDay 3 AgendaBack to Top